1 year ago
75 
Dwayne Senior/Bloomberg via Getty Images
HELLO and welcome to the first issue of 2022 – and our predictions of what the year ahead holds. This magazine went to press as the omicron variant of the coronavirus was on the rise. As the pandemic enters its third calendar year, we look at the likely evolution of further variants and the need for yet more boosters in the next 12 months.
Thankfully, news is cheerier elsewhere. The mRNA technology used in the Pfizer/BioNTech and Moderna coronavirus vaccines has gone from experimental to essential in record time, and researchers are investigating whether it can be used to treat everything …
